By Colin Kellaher Lyra Therapeutics on Monday said a late-stage study of its lead drug candidate missed its main goal in a chronic inflammatory sinus disorder. Lyra said the Phase 3 study.
By Colin Kellaher NextEra Energy has named top finance executive Kirk Crews to the newly created post of executive vice president and chief risk officer. NextEra on Monday said Brian.
By Colin Kellaher Shares of Perficient jumped nearly 55% in premarket trading Monday after the digital consultancy agreed to be acquired by Swedish private-equity firm EQT AB at an enterprise.
By Colin Kellaher Pfizer had hired Andrew Baum as the drugmaker s next chief strategy and innovation officer. Pfizer on Monday said Baum, who has been Citi s head of global healthcare and.
By Colin Kellaher A $16.5 billion deal aimed at boosting Novo Nordisk s production of the weight-loss drug Wegovy is drawing extra scrutiny from U.S. antitrust regulators. Novo Holdings,.